Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on: April 09,2024 0

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on:April 09,2024 0

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is

Updated on: April 09,2024 15

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is

Updated on:April 09,2024 15

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q

Updated on: April 09,2024 12

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q

Updated on:April 09,2024 12

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna

Updated on: April 09,2024 20

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna

Updated on:April 09,2024 20

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024 14

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024 14

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on: April 09,2024 13

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on:April 09,2024 13

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on: April 09,2024 16

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on:April 09,2024 16

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on: April 09,2024 18

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on:April 09,2024 18

Overall burden of tumor genome changes can predict patient outcomes

by eLifeKiller T cells surround a cancer cell. Credit: NIHResearchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types

Updated on: April 09,2024 16

Overall burden of tumor genome changes can predict patient outcomes

by eLifeKiller T cells surround a cancer cell. Credit: NIHResearchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types

Updated on:April 09,2024 16

Deadly lung cancers are driven by multiple genetic changes

by University of California, San FranciscoLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new UC San Francisco-led study challenges the dogma in oncology that mos

Updated on: April 09,2024 12

Deadly lung cancers are driven by multiple genetic changes

by University of California, San FranciscoLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new UC San Francisco-led study challenges the dogma in oncology that mos

Updated on:April 09,2024 12

Treating a rare genetic disorder that causes colon cancer in children

by Laurie Fickman,University of HoustonUniversity of Houston pharmaceutical scientist Ming Hu is developing a drug that will recycle and stay inside the area it is targeting. Credit: University

Updated on: April 09,2024 17

Treating a rare genetic disorder that causes colon cancer in children

by Laurie Fickman,University of HoustonUniversity of Houston pharmaceutical scientist Ming Hu is developing a drug that will recycle and stay inside the area it is targeting. Credit: University

Updated on:April 09,2024 17

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on: April 09,2024 19

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on:April 09,2024 19